Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilding

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I studyC J McGinn, K A Kunugi, K D Tutsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
Investigational New Drugs|January 9, 2009
A phase I study of an oral simulated FOLFOX with high dose capecitabineD Mulkerin, N K LoConte, K D Holen, et al.
Cancer|April 13, 2000
A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosisK M Hotton, M Khorsand, J A Hank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suraminP R Hutson, K D Tutsch, R Rago, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinomaR J Motzer, B A Murphy, J Bacik, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I studyC J McGinn, K A Kunugi, K D Tutsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
Investigational New Drugs|January 9, 2009
A phase I study of an oral simulated FOLFOX with high dose capecitabineD Mulkerin, N K LoConte, K D Holen, et al.
Cancer|April 13, 2000
A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosisK M Hotton, M Khorsand, J A Hank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suraminP R Hutson, K D Tutsch, R Rago, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinomaR J Motzer, B A Murphy, J Bacik, et al.
Pageof 11